文献速递关节外科

全膝关节置换术的多模式疼痛管理能否取消患者自控镇痛和股神经阻滞?

Can Multimodal Pain Management in TKA Eliminate Patient-controlled Analgesia and Femoral Nerve Blocks?
PubMed 文献 · Clin Orthop Relat Res · 2018-01-01

该回顾性研究分析了2013年9月至2015年9月共1808例初次全膝关节置换术患者,比较三个6个月期间疼痛管理方案变化对麻醉药用量、疼痛评分、功能恢复和出院去向的影响。结果显示取消患者自控镇痛和股神经阻滞并加用脂质体布比卡因后,麻醉药用量最少、功能恢复更快、出院回家比例更高,疼痛控制无差异,疼痛相关HCAHPS评分无差异。

要点

  • 取消患者自控镇痛和股神经阻滞并加用脂质体布比卡因后,总麻醉药用量最少(第3组66±54 vs 第2组82±72 vs 第1组96±62吗啡毫克当量,p<0.001)。
  • 第3组术后即刻疼痛评分升高(4.0±3.5 vs 1.2±2.2 vs 1.2±2.5,第2组与第3组事后分析均数差2.6,95%CI 2.2-3.0,p<0.001),但住院其余时间无差异。
  • 未使用患者自控镇痛的患者术后第1天步态和楼梯功能里程碑达标更快(47%[328/698] vs 30%[158/527] vs 16%[93/583],p<0.001;第3组vs第2组OR 2.1,95%CI 1.6-2.6,p<0.001)。

核心结论

  • 从多模式全膝关节置换术疼痛管理方案中取消患者自控镇痛和股神经阻滞并加用脂质体布比卡因,导致麻醉药用量减少、疼痛控制无差异、功能恢复更快,同时维持了较高的疼痛相关HCAHPS评分。

研究设计与样本

  • 回顾性分析机构关节置换数据库,纳入2013年9月至2015年9月共1808例初次全膝关节置换术患者,按6个月期间比较科室疼痛管理方案变化。
  • 所有患者均接受多模式疼痛管理方案,包括术前口服药物、脊髓或全身麻醉、术中短效关节囊周围注射以及术后继续口服麻醉药治疗突破性疼痛。
  • 2013年9月至2014年4月所有患者接受术中股神经阻滞和术后最初24小时患者自控镇痛(第1组);2014年5月至2014年10月加用脂质体布比卡因关节周围注射并取消股神经阻滞(第2组);2015年4月后取消患者自控镇痛(第3组)。
  • 证据等级:III级,治疗性研究。

主要发现

  • 总麻醉药用量第3组最少(第3组66±54 vs 第2组82±72 vs 第1组96±62吗啡毫克当量,p<0.001)。
  • 术后即刻疼痛评分第3组升高(4.0±3.5 vs 1.2±2.2 vs 1.2±2.5,第2组与第3组事后分析均数差2.6,95%CI 2.2-3.0,p<0.001),但住院其余时间无差异。
  • 未接受患者自控镇痛的患者术后第1天步态和楼梯功能里程碑达标更快(47%[328/698] vs 30%[158/527] vs 16%[93/583],p<0.001;第3组vs第2组OR 2.1,95%CI 1.6-2.6,p<0.001)。
  • 第3组出院回家比例更高(84%[583/698] vs 78%[410/527] vs 72%[421/583],p=0.010)。
  • 所有队列间疼痛相关HCAHPS评分无差异。

临床怎么用

  • 作者结论认为,取消患者自控镇痛和股神经阻滞并加用脂质体布比卡因可减少麻醉药用量、不差异疼痛控制、加快功能恢复并维持高HCAHPS评分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: TKA pain management protocols vary widely with no current consensus on a standardized pain management regimen. Multimodal TKA pain management protocols aim to address pain control, facilitate functional recovery, and maintain patient satisfaction. QUESTIONS/PURPOSES: (1) Did changes to our pain management protocol, specifically adding liposomal bupivacaine, eliminating patient-controlled analgesia (PCA), and discontinuing femoral nerve blocks (FNBs), affect narcotic consumption after TKA? (2) Did these changes to our pain management protocols affect patient-reported pain scores? (3) Does the use of an immediate postoperative PCA affect rapid rehabilitation and functional recovery? (4) How did changes to our pain management regimen affect discharge disposition and pain-related Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores? METHODS: We retrospectively analyzed an institutional arthroplasty database between September 2013 and September 2015 containing 1808 patients who underwent primary TKA. Departmental pain management protocols were compared in 6-month periods as the protocol changed. All patients received a multimodal pain management protocol including preoperative oral medications, spinal or general anesthesia, a short-acting intraoperative pericapsular injection, and continued postoperative oral narcotics for breakthrough pain. From September 2013 to April 2014, all patients received an intraoperative FNB and a PCA for the first 24 hours postoperatively (Cohort 1). From May 2014 to October 2014, a periarticular injection of liposomal bupivacaine was added to the protocol and FNBs were discontinued (Cohort 2). After April 2015, PCA was eliminated (Cohort 3). No other major changes were made to the TKA pain management pathways. Narcotic use, pain scores on 8-hour intervals, physical therapy milestones, and discharge disposition were compared. RESULTS: Total narcotic use was the least in Cohort 3 (Cohort 3: 66 ± 54 morphine milligram equivalents versus Cohort 2: 82 ± 72 versus Cohort 1: 96 ± 62; p < 0.001). There was an increase in pain score immediately after surgery in Cohort 3 (4.0 ± 3.5 versus 1.2 ± 2.2 versus 1.2 ± 2.5, post hoc analysis of Cohort 2 versus 3: mean difference 2.6, 95% confidence interval [CI] 2.2-3.0; p < 0.001); however, it was not different for the remainder of the hospital stay. Patients who did not receive PCA reached functional milestones for both gait and stairs faster by postoperative day 1 (47% [328 of 698] versus 30% [158 of 527] versus 16% [93 of 583], p < 0.001; Cohort 3 versus 2: odds ratio 2.1, 95% CI 1.6-2.6; p < 0.001). Discharge to home occurred more frequently (84% [583 of 698] versus 78% [410 of 527] versus 72% [421 of 583], p = 0.010) in Cohort 3. There were no differences in pain-related HCAHPS scores across all cohorts. CONCLUSIONS: Discontinuing PCAs and FNBs from our multimodal TKA pain management protocols and adding liposomal bupivacaine resulted in fewer narcotics consumed with no difference in pain control and faster functional recovery while maintaining high HCAHPS scores relating to pain. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Yu S, Dundon J, Solovyova O, et al. Can Multimodal Pain Management in TKA Eliminate Patient-controlled Analgesia and Femoral Nerve Blocks? Clin Orthop Relat Res. 2018. PMID: 29529623. doi:10.1007/s11999.0000000000000018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。